Search results
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
TV 7&4 Traverse City· 7 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN.com· 5 days agoThe US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 2 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 2 days agoNovavax Novavax (NASDAQ: NVAX) actually has gotten a start along the path to gains, soaring more...
Another COVID vaccine? Yes, and here’s why
San Jose Mercury News· 2 days agoThis fall, prepare for the latest round of COVID vaccine Whac-a-Mole. Protection against both infection and severe illness is waning. “Effectiveness has...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN via AOL· 5 days agoThe US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 vaccines to formulate their new shots to be a better match for the JN.1 ...
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 5 days agoIts success in the COVID-19 vaccine market catapulted it to new heights. However, once the pandemic began subsiding, with a substantial decline in ...
What to know about Moderna’s combined covid-flu vaccine on the horizon
Boston.com· 2 days agoModerna’s combined coronavirus-influenza shot reportedly produced a higher immune response in older...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 3 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 2 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine, announced ...
